
Loading, please wait...

Loading, please wait...

The SOUND randomized clinical trial asked whether sentinel lymph-node biopsy could be omitted altogether in women with small, clinically node-negative breast cancers when preoperative axillary ultrasonography showed no suspicious nodes. The study found that omission of axillary surgery was associated with excellent distant disease-free outcomes and did not compromise the broader treatment strategy in appropriately selected patients. This is an important step in surgical de-escalation because even sentinel-node biopsy is an invasive procedure with potential morbidity, although much less than full axillary dissection. The practical lesson for breast surgeons is that staging procedures should be proportional to the clinical question they need to answer. In carefully selected patients receiving modern breast cancer therapy, imaging and tumor characteristics may allow the axilla to be left untouched. The findings do not apply to every patient with breast cancer; tumor size, nodal imaging, biology and planned systemic or radiation treatment remain central to selection. SOUND therefore supports individualized, risk-adapted surgical planning.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The SOUND randomized clinical trial asked whether sentinel lymph-node biopsy could be omitted altogether in women with small, clinically node-negative breast cancers when preoperative axillary ultrasonography showed no suspicious nodes. The study found that omission of axillary surgery was associated with excellent distant disease-free outcomes and did not compromise the broader treatment strategy in appropriately selected patients. This is an important step in surgical de-escalation because even sentinel-node biopsy is an invasive procedure with potential morbidity, although much less than full axillary dissection. The practical lesson for breast surgeons is that staging procedures should be proportional to the clinical question they need to answer. In carefully selected patients receiving modern breast cancer therapy, imaging and tumor characteristics may allow the axilla to be left untouched. The findings do not apply to every patient with breast cancer; tumor size, nodal imaging, biology and planned systemic or radiation treatment remain central to selection. SOUND therefore supports individualized, risk-adapted surgical planning.
4 weeks back

A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
2 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
3 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
3 days back

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
4 days back